Diagnostic assertiveness of cerebellar pilocytic astrocytoma in the pediatric age

Keywords: Astrocytoma, pilocytic astrocytoma, low-grade brain tumors, quality of life, timely treatment


Pilocytic astrocytoma of the cerebellum in the pediatric age is the most frequent benign tumor lesion of the nervous system in children according to the WHO. International literature mentions that being low-grade tumors they have a high curative capacity. If the entire tumor is resected, when it is completely removed, survival increases with a high quality of life for children who presented this pathology and was treated on time. However, the delay in diagnosis and therefore in its treatment could generate the possibility of tumor transformation, the malignant nature of the transformed injuries has a very high morbidity and mortality, without mentioning that the degree of cognitive sequelae greatly affects the quality of life of the survivors. That is why the training of pediatric and non-pediatric first contact doctors imply a great responsibility since it gives the population and patients suffering from this nosology the possibility to improve their future life, as well as reduce the cost of the impact caused by the injuries they suffer. On the other hand, these tumors can transform generating devastating prognoses, without taking into account the economic and social repercussions of patients suffering from a low-grade tumor. When it is detected and treated assertively in a timely manner, it offers them greater opportunities than those who did not have such a timely diagnosis.


Download data is not yet available.


Alegría-Loyola MA, Galnares-Olalde JA, Mercado M. Tumors of the central nervous system. Rev Med Inst Mex Seguro Soc. 2017;55(3):330–40.

Central Brain Tumor Registry of the United States (CBTRUS). CBTRUS Fact sheet 2020. CBTRUS; 2020. https://cbtrus.org/cbtrus-fact-sheet-2020/

Ostrom QT, Patil N, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS. CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2013-2017. Neuro Oncol. 2020;22–96.

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.

Albright A, Pollack I, Adelson P. Principles and Practice of Pediatric Neurosurgery. In: Peruzzi P, Boué D, Courey R, editors. Cerebellar Astrocytomas. 3rd ed. New York: Thieme; 2013: 563 - 573.

Pollack IF, Agnihotri S, Broniscer A. Childhood brain tumors: current management, biological insights, and future directions: JNSPG 75th Anniversary Invited Review Article. J Neurosurg Pediatr. 2019;23(3):261–73.

Pollack IF. Brain tumors in children. N Engl J Med.1994; 331:1500–1507.

Kibirige MS, Birch JM, Campbell RHA, Gattamaneni HR, Blair V. A Review of Astrocytoma in Childhood. Pediatric Hematology and Oncology. 1989;6(4):319–329.

Zhukova N, Ramaswamy V, Remke M, Pfaff E, Shih DJ, Martin DC. Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma. J Clin Oncol. 2013; 31:2927–293.

Koeller KK, Rushing EJ. From the archives of the AFIP: pilocytic astrocytoma: radiologic-pathologic correlation: Pilocytic astrocytoma: Radiologic-pathologic correlation. Radiographics. 2004;24(6):1693–708

Knight J, De Jesus O. Pilocytic Astrocytoma. In StatPearls Publishings. 2021; 30 (4) 14-24.

Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, et al. The 2016 world health organization classification of tumors of the central nervous system: A summary. Acta Neuropathol. 2016;131(6):803–20.

Duffner PK, Krischer JP, Horowitz ME, Cohen ME, Burger PC, Friedman HS, et al. Second malignancies in young children with primary brain tumors following treatment with prolonged postoperative chemotherapy and delayed irradiation: a Pediatric Oncology Group study. Ann Neurol. 1998;44(3):313–6.

Bauchet L, Ostrom QT. Epidemiology and molecular epidemiology. Neurosurg Clin N Am. 2019;30(1):1–16.

Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. The 2021 WHO classification of tumors of the Central Nervous System: A summary. Neuro Oncol. 2021;23(8):1231–51.

Kruchko C, Ostrom QT, Gittleman H, Barnholtz-Sloan JS. The CBTRUS story: providing accurate population-based statistics on brain and other central nervous system tumors for everyone. Neuro Oncol. 2018;20(3):295–8.

Louis DN, Ohgaki H, Od W. The 2007 WHO classification of tumours of the central nervous sys- tem. Acta Neuropathol (Berl. 2007;114:97–109.

Chico-Ponce-De-León F, Castro-Sierra E, Perezpeña-Diazconti M, Gordillo-Domínguez LF, Santana-Montero BL, Rocha-Rivero LE, et al. Tumores intracraneanos del niño. Bol Med Hosp Infant Mex. 2006;63:367–381.

Matson D. Neurosurgery of infancy and childhood. 3rd ed. Springfield: Thomas; 1968: 934.

Hoffmann HJ, Kestle JRW. Craniopharyngiomas. In: Cheek WR, editor. 3rd ed. Philadelphia: WB Saunders Company; 1994: 418–28.

Ravi D, Vara Prasad K, Pallikonda V, Raman BS. Clinicopathological study of pediatric posterior fossa tumors. J Pediatr Neurosci. 2017;12(3):245.

Kaye AH, Morokoff A. The continuing evolution: biology and treatment of brain tumors. Neurosurgery. 2014;61 Suppl 1:100–4.

Packer RJ, Schut L, Sutton LN, Bruce DA. Brain tumors of the posterior cranial fossa in infants and children. In: En Y, editor. Philadelphia: WB Saunders Company; 1992. p. 3017–39.

De la Torre Mondragón L, Ridaura Sanz C, Reyes Mujica M, Rueda Franco F. Central nervous system tumors in Mexican children. Childs Nerv Syst. 1993;9(5):260–5.

Bourgeois M, Sainte–Rose C, Lellouch–Tubiana A, Malluci C, Brunelle F, Maixner V, et al. Surgery of epilepsy associated with focal lesions in childhood. J Neurosurg. 1999; 90: 833–42.

Paulas JE, Toga M, Hassoun J, Salamon G, Grisoli F. Les tumeurs cerebrales. Paris: Masson; 1982. p. 211.

Cohadon F. Fisiopatologfa de los tumores intracraneales. En: Decq P, Kéravel Y, Velasco F, editores. Neurocirugía. México: JGH Editores; 1999. p. 77–83.

González D, Loyo M. Tumores del sistema nervioso en el niño. Cir Cir. 1972;40:55–78.

Bruce DA, Schut L, Sutton LN. Supratentorial brain tumors in children. En: Youmans JR, editor. Neurological surgery. Philadelphia: WB Saunders Company; 1992. p. 3000–16.

Humphreys RP. Posterior cranial fossa brain tumors in children. In: Youmans JR, editor. Neurological surgery. Philadelphia: WB Saunders Company; 1982: 2733–58.

Tomita T. Miscellaneous posterior fossa tumors. In: CWR, editor. Philadelphia: WB Saunders Company; 1994: 383–91.

Edwards MSB, Baumgartner JE. Pineal region tumors. In: CWR, editor. Philadelphia: WB Saunders Company; 1994: 429–36.

Albright A, Pollack I, Adelson P. Principles and Practice of Pediatric Neurosurgery. In: Peruzzi P, Boué D, Courey R, editors. New York: Thieme; 1999: 491–514.

Kristiansen I, Strinnholm M, Strömberg B, Frisk P. Clinical characteristics, long-term complications and health-related quality of life (HRQoL) in children and young adults treated for low-grade astrocytoma in the posterior fossa in childhood. J Neurooncol. 2019;142(1):203–10.

Bornhorst M, Frappaz D, Packer RJ. Pilocytic astrocytomas. Handb Clin Neurol. 2016; 134:329–44.

Jones DT, Kocialkowski S, Liu L, Pearson DM, Bäcklund LM, Ichimura K. Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas. Cancer Res. 2008; 68:8673–8677.

Pfister S, Janzarik WG, Remke M, Ernst A, Werft W, Becker N, et al. BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas. J Clin Invest. 2008;118(5):1739–49.

Schindler G, Capper D, Meyer J, Janzarik W, Omran H, Herold-Mende C, et al. Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma. Acta Neuropathol. 2011;121(3):397–405.

Collins VP, Jones DTW, Giannini C. Pilocytic astrocytoma: pathology, molecular mechanisms and markers. Acta Neuropathol. 2015;129(6):775–88.

Collins KL, Pollack IF. Pediatric low-grade gliomas. Cancers (Basel). 2020;12(5):1152.

Tjota MY, Pytel P. Educational case: Pilocytic astrocytoma with atypical features. Acad Pathol. 2020;7:2374289520912498.

Sithanandam G, Kolch W, Duh FM, Rapp UR. Complete coding sequence of a human B-raf cDNA and detection of B-raf protein kinase with isozyme specific antibodies. Oncogene. 1990;5(12):1775–80.

Sithanandam G, Druck T, Cannizzaro LA, Leuzzi G, Huebner K, Rapp UR. B-raf and a B-raf pseudogene are located on 7q in man. Oncogene. 1992;7(4):795–9.

Reis GF, Tihan T. Practical Molecular Pathologic Diagnosis of Pilocytic Astrocytomas. Surgical Pathology Clinics. 2015;8(1):63–71.

Analysis of the BRAFV600E Mutation in Central Nervous System Tumors. Translational Oncology. 2012;5(6):430–436.

Raabe EH, Lim KS, Kim JM. BRAF activation induces transformation and then senescence in human neural stem cells: a pilocytic astrocytoma model. Clin Cancer Res. 2011; 17:3590–9.

Bergthold G, Bandopadhayay P, Bi WL, Ramkissoon L, Stiles C, Segal RA, et al. Pediatric low-grade gliomas: how modern biology reshapes the clinical field. Biochim Biophys Acta. 2014;1845(2):294–307.

Franco JJ, León F. Tiempo al diagnostico de los tumores cerebrales: Estrategia Snoopy para el diagnostico de lesiones tumoraes. Bol Med Hosp Infant Mex. 2018;63(6):367–381.

Anderson MD, Colen RR, Tremont-Lukats IW. Imaging mimics of primary malignant tumors of the central nervous system (CNS). Curr Oncol Rep. 2014;16(8):399.

Jiang Y, Lv L, Yin S, Zhou P, Jiang S. Primary spinal pilocytic astrocytoma: clinical study with long-term follow-up in 16 patients and a literature review. Neurosurg Rev. 2020;43(2):719–27.

Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114(5):547–547.

Goyal S, Puri T, Julka PK. Holocord low grade astrocytoma – Role of radical irradiation and chemotherapy. J Egypt Natl Canc Inst. 2015;27(2):105–8.

Onizuka H, Masui K, Komori T. Diffuse gliomas to date and beyond 2016 WHO Classification of Tumours of the Central Nervous System. Int J Clin Oncol. 2020;25(6):997–1003.

Giannini C, Scheithauer BW, Burger PC, Christensen MR, Wollan PC, Sebo TJ, et al. Cellular proliferation in pilocytic and diffuse astrocytomas. J Neuropathol Exp Neurol. 1999;58(1):46–53.

Gajjar A, Bhargava R, Jenkins JJ, Heideman R, Sanford RA, Langston JW, et al. Low-grade astrocytoma with neuraxis dissemination at diagnosis. J Neurosurg. 1995;83(1):67–71.

Ogiwara H, Bowman RM, Tomita T. Long-term follow-up of pediatric benign cerebellar astrocytomas. Neurosurgery. 2012;70(1):40–7.

Saunders DE, Phipps KP, Wade AM, Hayward RD. Surveillance imaging strategies following surgery and/or radiotherapy for childhood cerebellar low-grade astrocytoma. J Neurosurg Pediatr. 2005;102(2):172–8.

Milde T, Rodriguez FJ, Barnholtz-Sloan JS, Patil N, Eberhart CG, Gutmann DH. Reimagining pilocytic astrocytomas in the context of pediatric low-grade gliomas. Neuro Oncol. 2021.

Beni-Adani L, Gomori M, Spektor S, Constantini S. Cyst wall enhancement in pilocytic astrocytoma: neoplastic or reactive phenomena. Pediatr Neurosurg. 2000;32(5):234–9.

Austin EJ, Alvord EC Jr. Recurrences of cerebellar astrocytomas: a violation of Collins’ law. J Neurosurg. 1988;68(1):41–7.

Packer RJ, Lange B, Ater J, Nicholson HS, Allen J, Walker R, et al. Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood. J Clin Oncol. 1993;11(5):850–6.

Murphy ES, Parsai S, Kano H, Sheehan JP, Martinez-Alvarez R, Martinez-Moreno N, et al. Outcomes of stereotactic radiosurgery for pilocytic astrocytoma: an international multiinstitutional study. J Neurosurg. 2019;1–9.

How to Cite
Pichardo-Ávalos , A. L. (2022). Diagnostic assertiveness of cerebellar pilocytic astrocytoma in the pediatric age. Mexican Journal of Medical Research ICSA, 10(19), 41-47. https://doi.org/10.29057/mjmr.v10i19.7766